D Schlenzka - Non-Idiopathic Spine Deformities in Young Children, 2011 - Springer ... Type I: Acute infantile (Werdnig–Hoffmann) It becomes evident at birth or during the first months of life by muscle weakness and impaired breathing. ... Type II: Chronic infantile (Werdnig–Hoffmann) It starts at an age between 6 and 18 months. ... Related articles - All 2 versions
KC Bueno, SP Gouvea, AB Genari… - …, 2011 - content.karger.com ... Lancet 1980;i:919–922. 2. Czeizel A, Hamula J: A Hungarian study on Werdnig-Hoffmann disease. J Med Genet 1989;26:761–763. ... 16. Pearn JH: The gene frequency of acute Werdnig-Hofmann disease (SMA type I). A total population survey in Northeast England. ... Related articles - All 2 versions
[PDF] from dovepress.comL Bollag, CD Kent, P Richebé… - Local and Regional …, 2011 - dovepress.com ... SMA type I, first described by the Austrian and German neurologist duo of Werdnig Page 2. ... SMA type II, intermediate SMA, or in older literature referred to as chronic Werdnig-Hoffman disease is diagnosed in the first 6–24 months after birth. ... Related articles - View as HTML - All 3 versions
Y Ito, N Shibata, K Saito, M Kobayashi… - Brain and Development, 2011 - Elsevier ... neurological disorder characterized by progressive loss of lower motor neurons (LMNs) in the spinal cord and lower brain stem, associated with a resultant neurogenic muscular atrophy [1] and [2]. SMA is subclassified into three clinical phenotypes: Werdnig-Hoffmann disease ... Cited by 1 - Related articles - All 7 versions
SJ Kolb… - Archives of Neurology, 2011 - Am Med Assoc ... a PowerPoint slide]. Figure 1. Spinal muscular atrophy (SMA) timeline. Spinal muscular atrophy was first reported by Werdnig in 1891 and then by others who recognized variability of muscle weakness severity. A century later ... Cited by 1 - Related articles - All 2 versions
TB Grammer, MM Hoffmann, W Renner, ME Kleber… - Atherosclerosis, 2011 - Elsevier C-reactive protein (CRP) has been implicated in the development of atherosclerosis. The genetic polymorphism of apolipoprotein (apo) E is associated with the concentration of CRP. We analyzed the association between the apo E genotype, CRP and angiographic ... Related articles - All 6 versions
[HTML] from plos.org…, AR Shuldiner, JL Butler, M Tomas, U Hoffmann… - PLoS genetics, 2011 - dx.plos.org NAFLD is a spectrum of disease that ranges from steatosis to steatohepatitis (nonalcoholic steatohepatitis or NASH: inflammation around the fat) to fibrosis/cirrhosis. Hepatic steatosis can be measured non-invasively using computed tomography (CT) whereas NASH/fibrosis is assessed ... Cited by 8 - Related articles - Cached - All 14 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
